SCHEMBL6174034

SCHEMBL6174034

CC(c1ccnc(NC(=O)c2ccccc2Cl)c1)C1NC(=O)N(c2ccc(S(=O)(=O)C(F)(F)F)cc2)C1=O

nearest known ligand 0.37

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CBLB Q13191 8/20 0.36
ALDH1A1 P00352 2/20 0.36
KDM4E B2RXH2 1/20 0.36
HSD17B10 Q99714 1/20 0.36
IGF1R P08069 1/20 0.36
HTR2A P28223 1/20 0.35
TSPO P30536 1/20 0.35
GPR183 P32249 1/20 0.35
APLNR P35414 1/20 0.35
RXFP1 Q9HBX9 1/20 0.35
STIM1 Q13586 1/20 0.35
ORAI1 Q96D31 1/20 0.35
TP53 P04637 2/20 0.34
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34
POLB P06746 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6172184 0.88 NPC1 (0.39) CBLBALDH1A1IGF1RSTIM1ORAI1
SCHEMBL6175133 0.87 GRM5 (0.43) CBLBALDH1A1TP53NPC1RAB9A
SCHEMBL6177007 0.87 TDP1 (0.42) CBLBKDM4E
SCHEMBL6175934 0.87 IGF1R (0.41) CBLBALDH1A1IGF1RTP53NPC1
SCHEMBL6174110 0.85 NPC1 (0.39) CBLBALDH1A1IGF1RNPC1RAB9A
SCHEMBL6173893 0.84 LMNA (0.39) CBLBALDH1A1IGF1RHTR2ATSPO
SCHEMBL6176337 0.83 NPC1 (0.39) CBLBALDH1A1KDM4ETP53NPC1
SCHEMBL6174217 0.83 IGF1R (0.38) CBLBALDH1A1KDM4EIGF1RHTR2A
SCHEMBL6174834 0.83 GRM1 (0.39) CBLBIGF1RHTR2ATSPOGPR183
SCHEMBL6176514 0.83 NAMPT (0.41) IGF1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599464-A2 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS Aventis Pharma S.A. (FR) 2005-11-30 EP disclosed
WO-2004070050-A2 CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2004-08-19 WO disclosed